Medical Mysteries: Woman who develops colorblindness, diabetes gets rare diagnosis
Robert BostonWashington University Professor Fumihiko Urano, MD, PhD, holds dantrolene, an FDA-approved muscle relaxant that his research has shown may treat Wolfram syndrome, a rare but devastating condition. The university's Institute of Clinical and Translational Sciences (ICTS), which supports research that is likely to result in new therapies for patients, helped Urano's team understand the disease in the lab and then create a translational pipeline to investigate the drug in patients with Wolfram syndrome.
Source: The Washington Post
